Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

NCT06927648 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06927648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06927648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2025
Completion date
December 30, 2029
Enrollment
130 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer